FORMOSA PHARMACEUTICALS , INC.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
Formosa Pharma leverages its proprietary APNT® nanoparticle formulation platform to develop a diversified pipeline, including an FDA‑approved ophthalmic nanosuspension and biosimilar or new chemical entity candidates for cancer and anti‑infective applicat
Founded Year
2010
Unified Business No.
53273211
Status
Active
Number of Employees
0
Total Paid-in
Capital
1,509,771,000 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2021)、Listing(2024)
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Formosa Pharmaceuticals, Inc. is a Taipei‑based clinical‑stage biopharmaceutical company focusing on the development of novel therapies for ophthalmology and oncology.
